D-0597-2025 Class II Ongoing

Recalled by Cardinal Health Inc. — Dublin, OH

FDA drug recall D-0597-2025 was initiated by Cardinal Health Inc. on Aug 5, 2025 and is designated Class II. Reason for recall: Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL The recall status is ongoing. Affected quantity: 10 bags.

Recall details

Product Type
Drugs
Report Date
Sep 3, 2025
Initiation Date
Aug 5, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10 bags

Product description

Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefilled syringes, Rx Only, Dist. by: Sandoz Inc., Princeton, NJ 08540, Outer package - NDC 55154-3543-5, Inner label - NDC 0781-3238-01

Reason for recall

Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL

Distribution pattern

KS

Code information

Outer package - NDC 55154-3543-5, Lot SAD08033AA Inner label - NDC 0781-3238-01, Lot SAF13211A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0597-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0597-2025. Report a data issue: hello@regdatalab.com.